There is an increase in global demand of corona vaccine, German biotechnology company BioNTech is planning to produce two billion doses of corona vaccine in 2021 because of the increase in global demand.

In a press release, BioNTech,which developed the vaccine with US-based pharma Pfizer,  said, "In order to respond to an increased global demand, we plan to manufacture two billion doses of our COVID-19 vaccine in 2021 by expanding the previously expected output of 1.3 billion doses by more than 50 per cent." It further added, "We are on track to scale-up our manufacturing capacities."

The company said the modification of production processes at Pfizer's facility in Puurs, Belgium, had been successfully completed. It said, "The modification of production processes at Pfizer's facility in Puurs, Belgium, has been successfully completed. Now, we are back to the original schedule of vaccine dose deliveries to the European Union."

According to Johns Hopkins University, 103,409,402 corona cases have been recorded globally with over 2,237,973 deaths.

Also Read: 

American jobs won't return to pre-pandemic levels until 2024: CBO

India urges citizens to avoid unnecessary travel to Myanmar post military coup in Myanmar

South Africa Covid variant, Urgent testing after community spread